Versiti’s Banu Santebennur explains how clean data, semantic layers, and cautious tech adoption prepare clinical research for AI.
- Will AI And Agile Project Management Help Advance RBM?
- Building A Clinical Trial Tech Stack That Actually Works
- The Integration Dilemma: Who Decides Which Tech Stack Wins?
- Why Clinical Trial Sites Are Drowning In Tech Chaos
- The Risks And Unresolved Rules Of Real-Time Clinical Trials
- What Real-Time Clinical Trials Demand From Your Tech Stack
- The FDA's RTCT Push: What It Is; Why It Matters
- Pharma's Digital Transformation: Where It's Really At
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
3 Proven eConsent Implementation And Adoption Best Practices
By advocating these three essential best practices, learn how stakeholders can navigate the complexities of eConsent adoption with confidence and enhance the overall efficiency and success of clinical trials.
-
eConsent For Complex Clinical Trials
Master protocol design trials require an endless stream of consent forms, adding time, cost, and risk. Learn how a feature-rich eConsent platform can simplify those processes and improve engagement.
-
Partnership Driving Superior Enrollment And Speed In Phase III Trial
Examine the partnership between CRIO and Sitero, including how it underscores the significant impact of technology in optimizing trial performance and accelerating treatment development.
-
Why Scalable EDC Systems Matter In Global Pharmaceutical Trials
Sponsors who treat EDC as core infrastructure—not just software—are best positioned to succeed globally. Explore how EDC platforms keep studies compliant while enabling flexibility.
-
Unlocking The Value Of AI In IRT: Practical Perspectives From Vendors
AI can enhance IRT with predictive modeling and automation, but true success relies on high-quality data, compliance, and user trust. Learn practical strategies to boost efficiency.
-
Is Your Legacy EDC Limiting AI's Impact On Your Clinical Data?
AI can enhance clinical data workflows, but aging EDC systems hold teams back. This piece breaks down key barriers and shows what’s needed to modernize data foundations for meaningful AI adoption.
-
Rewind The Clock And Take TMF Back To Basics
Consider the evolution of Trial Master Files (TMF) in clinical trials when tackling the paradigm of maintaining simplicity while embracing technology.
-
Configurability And Customization: Key Features In An eTMF Solution
Discover how a configurable and customizable eTMF can lend itself to better information control during a clinical trial while boosting security and regulatory compliance efforts.
-
How EDCs Are Changing The Game In Clinical Research
Explore all things EDC in this article: what it is, how researchers can use it in clinical trials, its numerous benefits, and examples of how these translate into the real world.
-
With The Emergence Of DCTs, Do We Really Need A CTMS?
As decentralized trial designs continue to grow in popularity, do sponsors and CROs really need a clinical trial management system? Explore whether CTMS is necessary with the emergence of DCTs.
RECENT NEWSLETTERS
- 07.09.26 -- AI Governance, Real-Time Trials, And Hidden Risks to Watch
- 07.03.26 -- Best Of June: AI, Data, And What's Fixing Trial Execution
- 07.02.26 -- How AI And Real-Time Tech Are Changing Trial Execution
- 06.25.26 -- How AI, Data, And Workflows Are Fixing Trial Execution
- 06.18.26 -- AI, eSource, And Site Tech: What's Actually Working In Trials